{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:58:01Z","timestamp":1790931481418,"version":"4.1.0"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Clinical Psychopharmacology"],"published-print":{"date-parts":[[1998,3]]},"DOI":"10.1097\/00004850-199803003-00009","type":"journal-article","created":{"date-parts":[[2006,12,13]],"date-time":"2006-12-13T04:58:15Z","timestamp":1165985895000},"page":"S49-S58","source":"Crossref","is-referenced-by-count":55,"title":["Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia"],"prefix":"10.1097","volume":"13","author":[{"given":"Thomas R.E.","family":"Barnes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike A.","family":"McPhillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["International Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004850-199803003-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:12:14Z","timestamp":1786032734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004850-199803003-00009"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1097\/00004850-199803003-00009","relation":{},"ISSN":["0268-1315"],"issn-type":[{"value":"0268-1315","type":"print"}],"subject":[],"published":{"date-parts":[[1998,3]]}}}